AMGN: Amgen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 150,482.29
Enterprise Value ($M) 201,869.29
Book Value ($M) 7,527.00
Book Value / Share 14.00
Price / Book 19.99
NCAV ($M) -56,590.00
NCAV / Share -105.28
Price / NCAV -2.66

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.55

Liquidity (mrq)
Quick Ratio 0.96
Current Ratio 1.32

Balance Sheet (mrq) ($M)
Current Assets 26,766.00
Assets 90,883.00
Liabilities 83,356.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.16 2.02
01-30 13G/A State Street Corp 5.52 -0.73
01-25 13G/A BlackRock, Inc. 8.90 -1.45

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-02-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-20 577,968 2,432,279 23.76
2024-11-19 451,658 2,314,190 19.52
2024-11-18 409,739 2,420,011 16.93
2024-11-15 830,201 4,385,892 18.93

(click for more detail)

Similar Companies
ALLO – Allogene Therapeutics, Inc. ALNY – Alnylam Pharmaceuticals, Inc.
ALXO – ALX Oncology Holdings Inc. AMLX – Amylyx Pharmaceuticals, Inc.
AMPH – Amphastar Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Amgen Inc.